Antineoplastic AgentsNeoplasmsRadiation, IonizingRadiation DosageCell Line, TumorRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceDrug Screening Assays, AntitumorApoptosisDrug Resistance, NeoplasmRadiationMice, NudeCell SurvivalRadiation ProtectionXenograft Model Antitumor AssaysBreast NeoplasmsDrug Delivery SystemsRadiation MonitoringAntineoplastic Agents, PhytogenicCisplatinDoxorubicinGene Expression Regulation, NeoplasticCell ProliferationTumor Cells, CulturedColonic NeoplasmsLung NeoplasmsAntibiotics, AntineoplasticProstatic NeoplasmsEarly Detection of CancerRadiation OncologyOvarian NeoplasmsMolecular Targeted TherapyRadiotherapyDNA DamageCombined Modality TherapyDrug CarriersCell CycleNeoplasm ProteinsTumor Suppressor Protein p53Neoplasms, Radiation-InducedNeoplasm TransplantationNeoplasm MetastasisGamma RaysPaclitaxelRadiation-Sensitizing AgentsDose-Response Relationship, DrugAntineoplastic Combined Chemotherapy ProtocolsSignal TransductionPancreatic NeoplasmsRNA, Small InterferingStomach NeoplasmsCosmic RadiationClinical Trials as TopicNeoplasm InvasivenessDrug SynergismBlotting, WesternCamptothecinDrug DesignFluorouracilNanoparticlesRadiation Injuries, ExperimentalTransplantation, HeterologousModels, BiologicalCarcinoma, Squamous CellInhibitory Concentration 50Enzyme InhibitorsNanomedicineRadiation PneumonitisRadiotherapy DosageEtoposideCancer VaccinesCell DivisionTumor BurdenMutationReverse Transcriptase Polymerase Chain ReactionNeoplasms, ExperimentalRNA, MessengerDrug Resistance, MultipleNational Cancer Institute (U.S.)Neovascularization, PathologicCarcinoma, Non-Small-Cell LungCarcinomaDNA RepairHCT116 CellsAntimetabolites, AntineoplasticAdenocarcinomaRadiometryMCF-7 CellsP-GlycoproteinSurvival AnalysisUltraviolet RaysCell Transformation, NeoplasticDown-RegulationTime FactorsEllipticinesPrognosisFlow CytometryTumor Markers, BiologicalUterine Cervical Neoplasms